Literature DB >> 29626019

Diagnosis and management of sepsis.

Tom Evans1.   

Abstract

Sepsis is a common condition with high morbidity and mortality. Although many patients may require critical care, this article considers the features of sepsis that are of most relevance to acute general physicians. Recently updated definitions of sepsis and septic shock have been proposed which better identify patients who are likely to have a poor outcome, and therefore give an opportunity to escalate care. Despite these advances, there is still no molecular signature able to diagnose sepsis. Pathogenesis is complex, with many immune and non-immune mediators involved. Four key areas are endothelial dysfunction, coagulation abnormalities, alterations in cell function and dysregulated cardiovascular responses. No specific therapy targeting the mediators of sepsis has yet proven effective. Prompt administration of appropriate antibiotics is of benefit, together with fluid resuscitation and oxygen. © Royal College of Physicians 2018. All rights reserved.

Entities:  

Keywords:  critical care; infection; sepsis

Mesh:

Year:  2018        PMID: 29626019      PMCID: PMC6303466          DOI: 10.7861/clinmedicine.18-2-146

Source DB:  PubMed          Journal:  Clin Med (Lond)        ISSN: 1470-2118            Impact factor:   2.659


  20 in total

1.  The sepsis six and the severe sepsis resuscitation bundle: a prospective observational cohort study.

Authors:  Ron Daniels; Tim Nutbeam; Georgina McNamara; Clare Galvin
Journal:  Emerg Med J       Date:  2010-10-29       Impact factor: 2.740

2.  The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3).

Authors:  Mervyn Singer; Clifford S Deutschman; Christopher Warren Seymour; Manu Shankar-Hari; Djillali Annane; Michael Bauer; Rinaldo Bellomo; Gordon R Bernard; Jean-Daniel Chiche; Craig M Coopersmith; Richard S Hotchkiss; Mitchell M Levy; John C Marshall; Greg S Martin; Steven M Opal; Gordon D Rubenfeld; Tom van der Poll; Jean-Louis Vincent; Derek C Angus
Journal:  JAMA       Date:  2016-02-23       Impact factor: 56.272

3.  Assessment of Clinical Criteria for Sepsis: For the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3).

Authors:  Christopher W Seymour; Vincent X Liu; Theodore J Iwashyna; Frank M Brunkhorst; Thomas D Rea; André Scherag; Gordon Rubenfeld; Jeremy M Kahn; Manu Shankar-Hari; Mervyn Singer; Clifford S Deutschman; Gabriel J Escobar; Derek C Angus
Journal:  JAMA       Date:  2016-02-23       Impact factor: 56.272

4.  Management of Sepsis and Septic Shock.

Authors:  Michael D Howell; Andrew M Davis
Journal:  JAMA       Date:  2017-02-28       Impact factor: 56.272

5.  Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis.

Authors:  Anders Perner; Nicolai Haase; Anne B Guttormsen; Jyrki Tenhunen; Gudmundur Klemenzson; Anders Åneman; Kristian R Madsen; Morten H Møller; Jeanie M Elkjær; Lone M Poulsen; Asger Bendtsen; Robert Winding; Morten Steensen; Pawel Berezowicz; Peter Søe-Jensen; Morten Bestle; Kristian Strand; Jørgen Wiis; Jonathan O White; Klaus J Thornberg; Lars Quist; Jonas Nielsen; Lasse H Andersen; Lars B Holst; Katrin Thormar; Anne-Lene Kjældgaard; Maria L Fabritius; Frederik Mondrup; Frank C Pott; Thea P Møller; Per Winkel; Jørn Wetterslev
Journal:  N Engl J Med       Date:  2012-06-27       Impact factor: 91.245

6.  Nitric oxide and septic shock.

Authors:  J P Cobb; R L Danner
Journal:  JAMA       Date:  1996-04-17       Impact factor: 56.272

Review 7.  The immunopathogenesis of sepsis.

Authors:  Jonathan Cohen
Journal:  Nature       Date:  2002 Dec 19-26       Impact factor: 49.962

8.  Outcomes of the Surviving Sepsis Campaign in intensive care units in the USA and Europe: a prospective cohort study.

Authors:  Mitchell M Levy; Antonio Artigas; Gary S Phillips; Andrew Rhodes; Richard Beale; Tiffany Osborn; Jean-Louis Vincent; Sean Townsend; Stanley Lemeshow; R Phillip Dellinger
Journal:  Lancet Infect Dis       Date:  2012-10-26       Impact factor: 25.071

Review 9.  Sepsis: pathophysiology and clinical management.

Authors:  Jeffrey E Gotts; Michael A Matthay
Journal:  BMJ       Date:  2016-05-23

10.  Sepsis syndrome: a valid clinical entity. Methylprednisolone Severe Sepsis Study Group.

Authors:  R C Bone; C J Fisher; T P Clemmer; G J Slotman; C A Metz; R A Balk
Journal:  Crit Care Med       Date:  1989-05       Impact factor: 7.598

View more
  18 in total

Review 1.  Role of complement C5a and histones in septic cardiomyopathy.

Authors:  Fatemeh Fattahi; Lynn M Frydrych; Guowu Bian; Miriam Kalbitz; Todd J Herron; Elizabeth A Malan; Matthew J Delano; Peter A Ward
Journal:  Mol Immunol       Date:  2018-06-18       Impact factor: 4.407

2.  Outer membrane vesicles as molecular biomarkers for Gram-negative sepsis: Taking advantage of nature's perfect packages.

Authors:  Lea Vacca Michel; Thomas Gaborski
Journal:  J Biol Chem       Date:  2022-09-13       Impact factor: 5.486

3.  MG53 Protects against Sepsis-Induced Myocardial Dysfunction by Upregulating Peroxisome Proliferator-Activated Receptor-α.

Authors:  Xue Han; Daili Chen; Ning Liufu; Fengtao Ji; Qingshi Zeng; Weifeng Yao; Minghui Cao
Journal:  Oxid Med Cell Longev       Date:  2020-08-27       Impact factor: 6.543

Review 4.  Characterization of Pathogenic Sepsis Etiologies and Patient Profiles: A Novel Approach to Triage and Treatment.

Authors:  Hallie H Dolin; Thomas J Papadimos; Xiaohuan Chen; Zhixing K Pan
Journal:  Microbiol Insights       Date:  2019-01-27

5.  Hepatic PPARα function and lipid metabolic pathways are dysregulated in polymicrobial sepsis.

Authors:  Lise Van Wyngene; Tineke Vanderhaeghen; Steven Timmermans; Jolien Vandewalle; Kelly Van Looveren; Jolien Souffriau; Charlotte Wallaeys; Melanie Eggermont; Sam Ernst; Evelien Van Hamme; Amanda Gonçalves; Guy Eelen; Anneleen Remmerie; Charlotte L Scott; Caroline Rombouts; Lynn Vanhaecke; Liesbet De Bus; Johan Decruyenaere; Peter Carmeliet; Claude Libert
Journal:  EMBO Mol Med       Date:  2020-01-09       Impact factor: 12.137

Review 6.  Biomarkers for Point-of-Care Diagnosis of Sepsis.

Authors:  Andrew Teggert; Harish Datta; Zulfiqur Ali
Journal:  Micromachines (Basel)       Date:  2020-03-10       Impact factor: 2.891

Review 7.  Advances in sepsis diagnosis and management: a paradigm shift towards nanotechnology.

Authors:  Amit Pant; Irene Mackraj; Thirumala Govender
Journal:  J Biomed Sci       Date:  2021-01-08       Impact factor: 8.410

8.  Correlation of sPD1 with Procalcitonin and C-Reactive Protein Levels in Patients with Sepsis.

Authors:  Zahra Bakhshiani; Saloomeh Fouladi; Samaneh Mohammadzadeh; Nahid Eskandari
Journal:  Cell J       Date:  2021-03-01       Impact factor: 2.479

Review 9.  The Potential of Drug Delivery Nanosystems for Sepsis Treatment.

Authors:  Yi Shi; Meng-Lu Zhu; Qian Wu; Yi Huang; Xiao-Ling Xu; Wei Chen
Journal:  J Inflamm Res       Date:  2021-12-19

10.  AMPK activates Parkin independent autophagy and improves post sepsis immune defense against secondary bacterial lung infections.

Authors:  Nathaniel B Bone; Eugene J Becker; Maroof Husain; Shaoning Jiang; Anna A Zmijewska; Dae-Won Park; Balu Chacko; Victor Darley-Usmar; Murielle Grégoire; Jean-Marc Tadie; Victor J Thannickal; Jaroslaw W Zmijewski
Journal:  Sci Rep       Date:  2021-06-11       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.